Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort

IF 4.6 2区 医学 Q2 IMMUNOLOGY
Chun Zhang, Sun Chen, Yan Bian, Xiaohua Qian, Yurui Liu, Liqing Zhao, Jia Shen, Jiani Song, Peng Zhang, Lun Chen, Limin Jiang
{"title":"Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort","authors":"Chun Zhang,&nbsp;Sun Chen,&nbsp;Yan Bian,&nbsp;Xiaohua Qian,&nbsp;Yurui Liu,&nbsp;Liqing Zhao,&nbsp;Jia Shen,&nbsp;Jiani Song,&nbsp;Peng Zhang,&nbsp;Lun Chen,&nbsp;Limin Jiang","doi":"10.1002/cti2.1498","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>For children with Kawasaki disease (KD) at high risk of developing coronary artery lesions and requiring retreatment with intravenous immunoglobulin (IVIG), the availability of accurate prediction models remains limited because of inconsistent variables and unsatisfactory prediction results. We aimed to construct models to predict patient's probability of IVIG retreatment combining children's individual inflammatory characteristics.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Clinical manifestations and laboratory examinations of 266 children with KD were retrospectively analysed to build a development cohort data set (DC) and a validation cohort data set (VC). In the DC, binary logistic regression analyses were performed using R language. Nomograms and receiver operating curves were plotted. The concordance index (C index), net reclassification index, integrated discrimination improvement index and confusion matrix were applied to evaluate and validate the models.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Models_5V and _9V were established. Both contained variables including the percentages of CD8<sup>+</sup> T cells, CD4<sup>+</sup> T cells, CD3<sup>+</sup> T cells, levels of interleukin (IL)-2R and CRP. Model_9V additionally included variables for IL-6, TNF-α, NT-proBNP and sex, with a C index of 0.86 (95% CI 0.79–0.92). When model_9V was compared with model_5V, the NRI and IDI were 0.15 (95% CI 0.01–0.30, <i>P</i> &lt; 0.01) and 0.07 (95% CI 0.02–0.12, <i>P</i> &lt; 0.01). In the VC, the sensitivity, specificity and precision of model_9V were 1, 0.875 and 0.667, while those of model_5V were 0.833, 0.875 and 0.625.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Model_9V combined cytokine profiles and lymphocyte subsets with clinical characteristics and was superior to model_5V achieving satisfactory predictive power and providing a novel strategy early to identify patients who needed IVIG retreatment.</p>\n </section>\n </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.1498","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cti2.1498","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

For children with Kawasaki disease (KD) at high risk of developing coronary artery lesions and requiring retreatment with intravenous immunoglobulin (IVIG), the availability of accurate prediction models remains limited because of inconsistent variables and unsatisfactory prediction results. We aimed to construct models to predict patient's probability of IVIG retreatment combining children's individual inflammatory characteristics.

Methods

Clinical manifestations and laboratory examinations of 266 children with KD were retrospectively analysed to build a development cohort data set (DC) and a validation cohort data set (VC). In the DC, binary logistic regression analyses were performed using R language. Nomograms and receiver operating curves were plotted. The concordance index (C index), net reclassification index, integrated discrimination improvement index and confusion matrix were applied to evaluate and validate the models.

Results

Models_5V and _9V were established. Both contained variables including the percentages of CD8+ T cells, CD4+ T cells, CD3+ T cells, levels of interleukin (IL)-2R and CRP. Model_9V additionally included variables for IL-6, TNF-α, NT-proBNP and sex, with a C index of 0.86 (95% CI 0.79–0.92). When model_9V was compared with model_5V, the NRI and IDI were 0.15 (95% CI 0.01–0.30, P < 0.01) and 0.07 (95% CI 0.02–0.12, P < 0.01). In the VC, the sensitivity, specificity and precision of model_9V were 1, 0.875 and 0.667, while those of model_5V were 0.833, 0.875 and 0.625.

Conclusion

Model_9V combined cytokine profiles and lymphocyte subsets with clinical characteristics and was superior to model_5V achieving satisfactory predictive power and providing a novel strategy early to identify patients who needed IVIG retreatment.

Abstract Image

利用东亚队列中的淋巴细胞亚群和细胞因子谱相结合的模型,预测川崎病患儿静脉注射免疫球蛋白再治疗的效果
目的 对于有冠状动脉病变高风险并需要静脉注射免疫球蛋白(IVIG)再治疗的川崎病(KD)患儿,由于变量不一致和预测结果不理想,准确预测模型的可用性仍然有限。我们的目标是结合儿童的个体炎症特征,构建预测患者接受 IVIG 再治疗概率的模型。 方法 回顾性分析了266名KD患儿的临床表现和实验室检查,建立了开发队列数据集(DC)和验证队列数据集(VC)。在DC中,使用R语言进行了二元逻辑回归分析。绘制了提名图和接收者工作曲线。应用一致性指数(C 指数)、净再分类指数、综合辨别改进指数和混淆矩阵来评估和验证模型。 结果 建立了_5V 和_9V 模型。这两个模型都包含 CD8+ T 细胞、CD4+ T 细胞、CD3+ T 细胞百分比、白细胞介素(IL)-2R 水平和 CRP 等变量。模型 9V 还包括 IL-6、TNF-α、NT-proBNP 和性别等变量,C 指数为 0.86(95% CI 0.79-0.92)。模型 9V 与模型 5V 相比,NRI 和 IDI 分别为 0.15(95% CI 0.01-0.30,P< 0.01)和 0.07(95% CI 0.02-0.12,P< 0.01)。在 VC 中,模型_9V 的灵敏度、特异性和精确度分别为 1、0.875 和 0.667,而模型_5V 的灵敏度、特异性和精确度分别为 0.833、0.875 和 0.625。 结论 9V 模型将细胞因子图谱和淋巴细胞亚群与临床特征相结合,其预测能力优于 5V 模型,为早期识别需要 IVIG 再治疗的患者提供了一种新策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical & Translational Immunology
Clinical & Translational Immunology Medicine-Immunology and Allergy
CiteScore
12.00
自引率
1.70%
发文量
77
审稿时长
13 weeks
期刊介绍: Clinical & Translational Immunology is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. The Journal covers fields including cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信